trypt.am
Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

87 record(s) found.

Entheogen: psilocybin
Study Title: Psilocybin-assisted therapy for refractory Functional Neurological Disorder
Start Date: Mar 01, 2022
Conditions: Functional neurological disorder
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: psilocybin
Study Title: Safety and tolerability of psilocybin-assisted physiotherapy in healthy volunteers
Start Date: Mar 01, 2022
Conditions: Functional neurological disorder
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: psilocybin
Study Title: Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder
Start Date: Jan 15, 2022 - Last Update: July 29, 2021
Conditions: Amphetamine-Related Disorders
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD
Start Date: Dec 01, 2021 - Last Update: May 12, 2021
Conditions: Obsessive-compulsive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin Therapy for Depression in Bipolar II Disorder
Start Date: Nov 01, 2021 - Last Update: October 4, 2021
Conditions: Bipolar II Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
Start Date: Nov 01, 2021 - Last Update: October 5, 2021
Conditions: Hospice, Psilocybin, Demoralization, Terminal Illness, Cancer-related Problem/Condition, Psychotherapy, Terminal Cancer, Cancer Terminal
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-facilitated Treatment for Chronic Pain
Start Date: Nov 01, 2021 - Last Update: October 6, 2021
Conditions: Fibromyalgia, Primary
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Northwest Therapies Trauma Psilocybin Study Compassionate Use Study
Start Date: Oct 06, 2021 - Last Update: September 29, 2021
Conditions: Trauma, Nervous System
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Treatment-Resistant Depression
Start Date: Oct 01, 2021 - Last Update: September 5, 2021
Conditions: Treatment Resistant Depression
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Evaluation of Psilocybin (TRP-8802) to Decrease Hyperphagia
Start Date: Oct 01, 2021 - Last Update: September 5, 2021
Conditions: Hyperphagia
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults
Start Date: Sep 15, 2021 - Last Update: August 26, 2021
Conditions: Anxiety and Depression
Location(s): Jamaica
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Visual Surround Suppression and Perceptual Expectation Under Psilocybin
Start Date: Aug 30, 2021 - Last Update: September 1, 2021
Conditions: Perception Disturbance, Visual Suppression, Psychedelic Experiences
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer
Start Date: Aug 26, 2021 - Last Update: August 30, 2021
Conditions: Cancer
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
Start Date: Aug 15, 2021 - Last Update: September 5, 2021
Conditions: Parkinson Disease, Depression, Anxiety
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness
Start Date: Aug 11, 2021 - Last Update: August 18, 2021
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Phase 1b Study in Patients With Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)
Start Date: Aug 11, 2021 - Last Update: September 16, 2021
Conditions: Short Lasting Unilateral Neuralgiform Headache Attacks
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Repeat Dosing of Psilocybin in Migraine Headache
Start Date: Aug 01, 2021 - Last Update: August 2, 2021
Conditions: Migraine Headache
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Psychological and Existential Distress in Palliative Care
Start Date: Aug 01, 2021 - Last Update: April 1, 2021
Conditions: Depression, Anxiety, Distress, Emotional
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
Start Date: Jun 10, 2021 - Last Update: July 29, 2021
Conditions: Treatment-resistant Depression
Location(s): Germany
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Precision Functional Brain Mapping in Psilocybin
Start Date: Jun 01, 2021 - Last Update: July 28, 2021
Conditions: Psilocybin
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
Start Date: May 28, 2021 - Last Update: August 25, 2021
Conditions: Anorexia Nervosa
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Pilot RECAP Study in Healthy Normal Volunteers
Start Date: May 21, 2021 - Last Update: September 24, 2021
Conditions: Psychedelic Experiences, Amnesia
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy
Start Date: May 01, 2021 - Last Update: June 4, 2021
Conditions: Anorexia Nervosa
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
Start Date: Apr 14, 2021 - Last Update: April 15, 2021
Conditions: Major Depressive Disorder, Alcohol Use Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Start Date: Mar 24, 2021 - Last Update: March 26, 2021
Conditions: Depressive Symptoms, Depression, Alzheimer Disease, Mild Cognitive Impairment
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
Start Date: Mar 01, 2021 - Last Update: March 3, 2021
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.
Start Date: Mar 01, 2021 - Last Update: March 3, 2021
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder
Start Date: Feb 26, 2021 - Last Update: March 16, 2021
Conditions: Body Dysmorphic Disorders
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder
Start Date: Feb 18, 2021 - Last Update: August 24, 2021
Conditions: Alcohol Use Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
Start Date: Jan 20, 2021 - Last Update: January 28, 2021
Conditions: Alcohol Use Disorder (AUD)
Location(s): Denmark
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Adjunctive Effects of Psilocybin and Buprenorphine
Start Date: Jan 13, 2021 - Last Update: August 12, 2021
Conditions: Opioid Use Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density
Start Date: Jan 01, 2021 - Last Update: December 19, 2020
Conditions: Major Depressive Disorder, Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Can a one-off administration of psilocybin reduce alcohol intake in patients with alcohol use disorder? A randomized, double-blinded, placebo-controlled clinical trial.
Start Date: Dec 16, 2020
Conditions: Alcohol Use Disorder
Location(s): Denmark
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression
Start Date: Sep 15, 2020 - Last Update: September 27, 2021
Conditions: Treatment Resistant Depression
Location(s): United States, Ireland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin in Depression Resistant to Standard Treatments
Start Date: Sep 01, 2020 - Last Update: July 22, 2021
Conditions: Treatment Resistant Depression
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
Start Date: Sep 01, 2020 - Last Update: October 20, 2020
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: A randomised, placebo controlled trial of psilocybin in treatment resistant depression: A feasibility study
Start Date: Aug 27, 2020
Conditions: Major depressive disorder
Location(s): United Kingdom(United Kingdom, -, no, longer, in, EU/EstoniaA)
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)
Start Date: Jul 20, 2020 - Last Update: March 3, 2021
Conditions: Treatment Resistant Depression
Location(s): United States, Czechia, Ireland, Netherlands, United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: A multicentre study to assess safety and efficacy of psilocybin in patients with treatment-resistant depression following completion of COMP 001 and COMP 003 trials (P-TRD LTFU)
Start Date: Jul 08, 2020
Conditions: Treatment-Resistant Depression (P-TRD)
Location(s): Portugal, Czech Republic, Denmark, Netherlands, Germany
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: Characterization of Altered Waking States of Consciousness in Healthy Humans
Start Date: Jul 08, 2020 - Last Update: April 29, 2021
Conditions: Altered Waking States of Consciousness in Healthy Humans
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder
Start Date: Jun 30, 2020 - Last Update: September 30, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients
Start Date: Jun 08, 2020 - Last Update: July 22, 2020
Conditions: Alcohol Use Disorder
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Comparative Acute Effects of LSD, Psilocybin and Mescaline
Start Date: May 19, 2020 - Last Update: September 8, 2021
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Prophylactic Effects of Psilocybin on Chronic Cluster Headache
Start Date: Jan 21, 2020 - Last Update: February 21, 2020
Conditions: Cluster Headache
Location(s): Denmark
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Effect of 3, 4-Methylenedioxymethamphetamine (MDMA)-assisted therapy on Mood and Anxiety symptoms in advanced-stage Cancer Study
Start Date: Jan 06, 2020
Conditions: Depression symptoms, Anxiety symptoms, Advanced-stage cancer
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: psilocybin
Study Title: The Canadian Underage Substance Use Prevention Trial
Start Date: Dec 01, 2019 - Last Update: December 17, 2019
Conditions: Substance Use Disorders, Adolescent Behavior, Adolescent Development
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: A Study of Psilocybin for Major Depressive Disorder (MDD)
Start Date: Oct 15, 2019 - Last Update: September 30, 2021
Conditions: Depressive Disorder, Major
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-assisted psychotherapy for the treatment of depression and anxiety associated with life-threatening illness
Start Date: Sep 27, 2019
Conditions: Depression in terminal illness (any palliative condition including malignant and non-malignant terminal illnesses), Anxiety in terminal illness (any palliative condition including malignant and non-malignan terminal illnesses)
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: psilocybin
Study Title: Effects of Psilocybin in Anorexia Nervosa
Start Date: Aug 26, 2019 - Last Update: November 24, 2020
Conditions: Anorexia Nervosa
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects
Start Date: Jul 04, 2019 - Last Update: December 1, 2020
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis
Start Date: Apr 11, 2019 - Last Update: August 13, 2019
Conditions: Parkinson Disease Psychosis
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of Psilocybin in Concussion Headache
Start Date: Mar 28, 2019 - Last Update: August 9, 2021
Conditions: Post-Traumatic Headache
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin
Start Date: Mar 27, 2019 - Last Update: April 27, 2021
Conditions: Healthy
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept
Start Date: Mar 11, 2019 - Last Update: September 30, 2021
Conditions: Depressive Disorder, Major
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
Start Date: Mar 01, 2019 - Last Update: June 29, 2021
Conditions: Treatment Resistant Depression
Location(s): United States, Canada, Czechia, Denmark, Germany, Ireland, Netherlands, Portugal, Spain, United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms
Start Date: Jan 07, 2019 - Last Update: July 31, 2020
Conditions: Depressive Disorder, Major
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Treatment of Obsessive Compulsive Disorder
Start Date: Jan 02, 2019 - Last Update: June 10, 2021
Conditions: Obsessive-compulsive Disorder (OCD)
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
Start Date: Nov 13, 2018 - Last Update: May 19, 2021
Conditions: Obsessive-Compulsive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin and Depression
Start Date: Sep 01, 2018 - Last Update: December 21, 2017
Conditions: Severe Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
Start Date: Jun 30, 2018 - Last Update: July 30, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin vs. escitalopram for major depressive disorder: comparative mechanisms
Start Date: Apr 09, 2018
Conditions: Major Depressive Disorder
Location(s): United Kingdom
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
Start Date: Jan 05, 2018 - Last Update: January 7, 2021
Conditions: Distress, Depression, Grief
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for the Treatment of Migraine Headache
Start Date: Nov 01, 2017 - Last Update: January 7, 2021
Conditions: Migraine Headache
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of Psilocybin in Major Depressive Disorder
Start Date: Aug 10, 2017 - Last Update: December 11, 2020
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Persisting Effects of Psilocybin
Start Date: Jul 01, 2017 - Last Update: September 10, 2019
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders
Start Date: May 31, 2017 - Last Update: September 8, 2021
Conditions: Patients, Anxiety Disorders
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin as a tool for enhancing cognitive flexibility
Start Date: May 01, 2017 - Last Update:
Conditions: psilocybin, divergent thinking, neurotransmission
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: psilocybin
Study Title: The Neurobiological Effect of 5-HT2AR Modulation
Start Date: Mar 03, 2017 - Last Update: August 13, 2020
Conditions: Basic Science
Location(s): Denmark
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for the Treatment of Cluster Headache
Start Date: Nov 01, 2016 - Last Update: September 13, 2021
Conditions: Cluster Headache
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-facilitated Treatment for Cocaine Use
Start Date: May 01, 2015 - Last Update: July 26, 2021
Conditions: Cocaine-Related Disorders
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals
Start Date: Apr 01, 2015 - Last Update: March 25, 2021
Conditions: Religious or Spiritual Problem
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion
Start Date: Mar 01, 2015 - Last Update: August 10, 2021
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Assessing the subjective intensity of oral psilocybin in patients with treatment-resistant depression: A Pilot Study
Start Date: Jan 07, 2015
Conditions: Major depressive disorder
Location(s): United Kingdom
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: Animal and human serotonergic model of schizophrenia: validity evaluated by qEEG and fMRI
Start Date: Jun 18, 2014
Conditions: Inclusion criteria:
Location(s): Czech Republic
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence
Start Date: Jun 01, 2014 - Last Update: May 25, 2021
Conditions: Alcohol Dependence
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: UW Psilocybin Pharmacokinetics Study
Start Date: Jun 01, 2014 - Last Update: April 15, 2020
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of Hallucinogens and Other Drugs on Mood and Performance
Start Date: Apr 01, 2014 - Last Update: May 16, 2019
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self
Start Date: Oct 01, 2013 - Last Update: November 4, 2020
Conditions: Healthy
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Start Date: May 01, 2013 - Last Update: May 20, 2014
Conditions: Psilocybin, Hallucinogens, Pharmacologic Actions, Central Nervous System Agents, Therapeutic Uses, Psychotropic Drugs
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma
Start Date: Jan 01, 2012 - Last Update: September 17, 2014
Conditions: Anxiety, Stage IV Melanoma
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence
Start Date: Jan 01, 2012 - Last Update: February 10, 2014
Conditions: Alcohol Dependence
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin and Spiritual Practice
Start Date: Aug 01, 2009 - Last Update: February 24, 2016
Conditions: Healthy
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin Cancer Anxiety Study
Start Date: Feb 01, 2009 - Last Update: October 20, 2020
Conditions: Cancer
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
Start Date: Sep 01, 2008 - Last Update: October 4, 2021
Conditions: Nicotine Dependence
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psychopharmacology of Psilocybin in Cancer Patients
Start Date: Apr 01, 2007 - Last Update: July 19, 2018
Conditions: Depressive Symptoms, Anxiety, Cancer
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
Start Date: Apr 01, 2004 - Last Update: January 29, 2013
Conditions: Anxiety
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The safety and efficacy of psilocybin as an adjunctive therapy in participants with treatment-resistant depression
Start Date:
Conditions: treatment resistant depression
Location(s): Ireland(Restarted)
Source: www.clinicaltrialsregister.eu
short summary


Total execution time in seconds: 0.019325017929077
×

About Trypt.am

Trypt.am is a project sponsored by Entheos Foundation of New Zealand (https://entheos.org.nz). The data is taken from several publicly available clinical trials from around the world.

Trypt.am pulls a subset of the clinical trials based on psychedelic substances. This website is in beta, and only exists for informational purposes. There still may be bugs and inaccurate data, it is up to the user to use the data as they see fit.

This site uses no trackers, cookies, and no data is collected from visitors of this site.

Trypt.am is a shortening for the word *tryptamine*.

If you would like to contribute to the code base or report bugs, please contact:
info (at) entheos (dot) org (dot) nz